HYPERHEP BS/D (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the HYPERHEP B drug offered from GRIFOLS USA, LLC. This Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
| NON-PROPRIETARY NAME: | HEPATITIS B IMMUNE GLOBULIN (HUMAN) |
| SUBSTANCE NAME: | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1996-10-09 |
| END MARKETING DATE: | 0000-00-00 |
HYPERHEP B S/D PLASMA DERIVATIVE Details:
| Item Description | HYPERHEP B S/D from GRIFOLS USA, LLC |
| LABELER NAME: | GRIFOLS USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 220([iU]/mL) |
| START MARKETING DATE: | 1996-10-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13533-636_5e516db1-4145-44b5-8152-f884040c1755 |
| PRODUCT NDC: | 13533-636 |
| APPLICATION NUMBER: | BLA101146 |
Other HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:
